BMJ10d
bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
Correspondence to Professor Norbert Blank, Heidelberg University Hospital Department of Hematology Oncology and Rheumatology, Heidelberg, Baden-Württemberg, Germany; ...
BMJ13d
Validation and incorporation of digital entheses into a preliminary GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis
Objectives The main objective was to generate a GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis and to test its reliability. To this end, we assessed the validity, ...
BMJ2d
Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era
Correspondence to Ping-Hsuan Hsieh, Health Economics and Health Technology Assessment, University of Glasgow Institute of Health and Wellbeing, Glasgow G12 8RZ, UK; p.hsieh.1{at}research.gla.ac.uk ...
BMJ2d
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Correspondence to Dr Elizabeth R Volkmann, Department of Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA; evolkmann{at}mednet.ucla.edu ...
BMJ2d
FRI0220 Allogeneic mesenchymal precursor cells (MPCS): a novel approach to treating biologic refractory rheumatoid arthritis
Background Allogeneic STRO-3 immunoselected mesenchymal precursor cells (MPCs) derived from bone marrow of healthy donors are a potent, homogeneous cell population which can be activated by ...
BMJ9d
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
Correspondence to Dr Jörg H W Distler, Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, ...
BMJ4d
Immunopathology of psoriasis and psoriatic arthritis
Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate it from rheumatoid arthritis (RA). Attempts to identify immunopathological mechanisms, some shared ...
BMJ2d
IL-1 Trap rilonacept in refractory adult onset Still's disease
2 Department of Rheumatology, Baylor University Medical Center, Baylor Research Institute, Dallas, Texas, USA 3 Division of Rheumatogy, Lincoln Medical and Mental Health Center and Weill Cornell ...
BMJ9d
Association between age and knee structural change: a cross sectional MRI based study
Objective: To describe the associations between age, knee cartilage morphology, and bone size in adults. Methods: A cross sectional convenience sample of 372 male and female subjects (mean age 45 ...
BMJ6d
Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21
Correspondence to Mr Xinyu Yang, Xinyu Yang, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China; cyrillyoung{at}163.com and Dr ...
BMJ13d
ANCA antibodies in Graves' disease
1 Rheumatology Section, Hospital Universitari Germans Trias i Pujol, Crta del Canyet s/n Badalona, 08916 Barcelona, Spain; aolive@ns.hugtip.scs.es 2 Immunology Section, Hospital Universitari Germans ...
BMJ12d
Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women
Objectives: To examine the effect of reproductive history and use of hormonal therapies on the risk of hip and knee joint replacement for osteoarthritis. Methods: A prospective study of 1.3 million ...